Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of auricular vagal neuromodulation therapy aVNT on adults with Prader-Willi Syndrome PWS, a rare neurodevelopmental disorder. The study aims to assess how daily aVNT stimulation impacts emotional control, executive functions such as planning and flexibility, hyperphagia, depression, and quality of life. This is the first multicenter randomized controlled trial exploring aVNT as a treatment for PWS, which currently has no therapies addressing its many behavioral and cognitive challenges. Participants will be randomly assigned to receive either active or sham aVNT stimulation using a small portable device with electrodes placed on the left ear. The stimulation sessions last four hours per day, seven days a week, over nine months. The device delivers painless electrical microcurrents to stimulate the auricular branch of the vagus nerve. Active stimulation is adjusted by participants for comfort and occurs during relaxing activities. The sham group uses the same device but with stimulation applied to an area without vagus nerve fibers. During the study, emotional control will be measured every two weeks for eleven months, including before and after the stimulation period. Other outcomes like executive functioning, hyperphagia, depression, and quality of life will be assessed four times before treatment, and at three, six, and nine months. Participants and their caregivers will be involved in evaluations. The study includes safety monitoring and aims to understand the persistence of effects after stimulation ends.
Actively Recruiting
Healthy Volunteer
Researchers are conducting a longitudinal observational study focused on people with profound intellectual and multiple disabilities PIMDPolyhandicap and their caregivers. This study aims to expand the representativeness of the existing EVAL-PLH cohort by including participants from a wider geographical area and non-public care structures. The goal is to better understand the health status, clinical practices, and the experiences of patients and their family and institutional caregivers over time. Participants include people with PIMDPolyhandicap, their family caregivers, and institutional caregivers. Data collection involves completing questionnaires about health status, quality of life, and care management. This third wave builds on prior waves conducted in 2015-2016 and 2020-2021, providing a richer, more detailed view of the evolving needs and care environments of this population. Participants will be asked to complete various questionnaires a 2-hour health status survey for patients, shorter questionnaires for caregivers, and assessments by physicians. The study monitors changes over time in health, clinical practices, and caregiver experiences. Participation involves completing self-reported questionnaires and providing information over the study duration, with results helping to inform healthcare decision-making and support services. The study is sponsored by Assistance Publique Hopitaux De Marseille and is expected to continue until 2028.